Gino Villetti

AGENT FOR TREATMENT OF DERMATOLOGICAL DISORDERS

COMBINED TREATMENT OF BRAIN INJURY

AGENT FOR USE IN TREATMENT OR PREVENTION OF OPHTHALMIC DISORDERS

USE OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOL DERIVATIVES FOR TREATING CYSTIC FIBROSIS

AGENT FOR TREATMENT OF DERMATOLOGICAL DISORDERS

USE OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOL DERIVATIVES FOR TREATING CYSTIC FIBROSIS

Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors

DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS

DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS

1-(2-FLUOROBIPHENYL-4-YL)-CYCLOPROPANECARBOXYLIC ACID DERIVATIVES FOR THE THERAPY OF PRION DISEASES

1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases

1-(2-fluorobiphenyl-4-yl)-alkyl carboxylic acid derivatives for the therapy of transthyretin amyloidosis

1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases

ANTI-AMYLOID IMMUNOGENIC COMPOSITIONS, METHODS AND USES

ANTI-AMYLOID IMMUNOGENIC COMPOSITIONS, METHODS AND USES

COMPOSITIONS COMPRISING AN ANTIMUSCARINIC AND A LONG-ACTING BETA-AGONIST

Ester derivatives as phosphodiesterase inhibitors

Azole Derivatives With Antimuscarinic Activity

Therapeutic Combination Comprising a Nmda Receptors Blocker and a Narcotic Analgesic Substance

Derivatives of 1-phenylalkanecarboxylic acids for the treatment of neurodegenerative diseases

Quinuclidine derivatives as M3 antagonists

Anti-amyloid immunogenic compositions, methods and uses

1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases

2-indanylamino derivatives for the therapy of chronic pain